Sarah Ford | November 20, 2014
Drug Restores Memory Function in Alzheimer’s Model
Building on earlier work funded by BrightFocus, researchers have discovered a promising new drug compound that reverses some
Alzheimer’s effects on memory in mice.Â
Four years ago, a research team led by BrightFocus grantee and Nobel Laureate Dr. Paul Greengard established the connection between increased striatal-enriched tyrosine phosphatase (STEP) levels and Alzheimer’s changes in mice, and showed that removing STEP had the effect of restoring synaptic connections.Â
Since their discovery of STEP, this research team has been searching for a drug that would block its damaging effects on brain synapses. They focused their efforts on finding a STEP inhibitor, studying thousands of small molecules in their quest.Â
Get Resources and Insights Straight To Your Inbox
Explore More Articles
Emergency Assistance Fund Compliance: How to Stay IRS-Compliant While Maximizing Employee Impact
Why Emergency Assistance Funds Matter More Than Ever Financial insecurity remains a critical challenge for today’s workforce. Approximately 37% of Americans cannot afford an unexpected…
Open Position – Director of Marketing
Position: Director of Marketing Department: Business Development Reporting Structure: VP, Business Development Exemption Status: Exempt Location: Remote Overview of the Role: Reporting to, and partnering with, the VP,…
Get Resources and Insights Straight To Your Inbox
Receive our monthly/bi-monthly newsletter filled with information about causes, nonprofit impact, and topics important for corporate social responsibility and employee engagement professionals, including disaster response, workplace giving, matching gifts, employee assistance funds, volunteering, scholarship award program management, grantmaking, and other philanthropic initiatives.